Founded in 2008, American CryoStem Corporation is a biotechnology pioneer, standardizing adipose tissue derived technologies for the fields of Regenerative and Personalized Medicine. CRYO is dedicated to supporting patients, and families in their pursuit of maintaining a healthy life and well-being today and in the future.
The Company maintains a world class portfolio of intellectual property and patented technologies and operates a state-of-art, FDA-registered, laboratory in Princeton, NJ dedicated to the collection, processing, bio-banking, culturing and differentiation of autologous adipose tissue (fat) and adipose derived stem cells (ADSCs) for use in Regenerative and Personalized Medicine.